methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate

We are methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate CAS:178306-47-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate
CAS.NO:  178306-47-3
Synonyms:methyl 2-hydroxy-3-methoxy-3,3-diphenylpropionate
methylhydroxymethoxydiphenylpropanoate
(S)-2-HYDROXY-3-METHOXY-3,3-DIPHENYLPROPIONIC ACID METHYL ESTER
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester
Benzenepropanoicacid,a-hydroxy-b-methoxy-b-phenyl-,methylester

Molecular Formula: C17H18O4
Molecular Weight:286.32200

Physical and Chemical Properties:
Density: 1.176g/cm3
Boiling point: 440.722ºC at 760 mmHg
Melting point: /
Flash point: 159.393ºC
Refractive index: 1.56

Specification:
Appearance:  White Crystal Solid
Purity: 99％
Water:0.5% Max.
Sulfated ash:0.1% Max.
Heavy metals:10ppm Max
Total Impurity:0.5% Max.
Total plate count:≤1000cfu/g
Yeast and Moulds:≤100cfu/g

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Application:Intermediates of Ambrisentan CAS:177036-94-1

Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.4-bromo-2-trifluorometoxianilina CAS:175278-09-8 At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.1,2,3-Trifluorobenzene At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.4-Dibenzothienylboronic acid It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.